Tyra Biosciences, Inc.

TYRA · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $2.0B · 87 employees
72
SEC Filings
$28.65
Close 2026-09-04
87
Employees

Business Summary

Tyra Biosciences is a clinical-stage biotechnology company developing next-generation precision medicines targeting FGFR biology for oncology and genetically defined conditions. Its lead product, oral dabogratinib (formerly TYRA-300), is an FGFR3-selective inhibitor in Phase 2 trials for low-grade upper tract urothelial carcinoma, intermediate risk non-muscle invasive bladder cancer, and achondroplasia. The company also has TYRA-430 (FGFR4/3 biased, Phase 1 for HCC) and TYRA-200 (FGFR1/2/3 inhibitor, Phase 1 for ICC). All assets are developed in-house using its proprietary SNP platform.

Latest Stock Quote

TYRA 2026-09-04 $28.65 O:$24.51 H:$29.56 L:$24.51 Vol:1.9M VWAP:$28.3746
origin leaf: null

Next Earnings

expected 2026-12-09

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-022025-12-310001193125-26-085490EDGAR87K words
2025-03-272024-12-310000950170-25-046124EDGAR88K words
2024-03-192023-12-310000950170-24-033461EDGAR96K words
2023-03-222022-12-310000950170-23-009181EDGAR95K words
2022-03-032021-12-310000950170-22-002814EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-042026-06-300001193125-26-332995EDGAR18K words
2025-11-052025-09-300001193125-25-266967EDGAR18K words
2025-08-142025-06-300000950170-25-108899EDGAR18K words
2025-05-082025-03-310000950170-25-066942EDGAR17K words
2024-11-072024-09-300000950170-24-123346EDGAR19K words
2024-08-072024-06-300000950170-24-092778EDGAR18K words
2024-05-092024-03-310000950170-24-056971EDGAR16K words
2023-11-072023-09-300000950170-23-060276EDGAR16K words
2023-08-102023-06-300000950170-23-041382EDGAR16K words
2023-05-042023-03-310000950170-23-017875EDGAR14K words
2022-11-032022-09-300000950170-22-021937EDGAR17K words
2022-08-042022-06-300000950170-22-014802EDGAR15K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-150001193125-26-390951EDGAR1K words
2026-09-090001193125-26-385886EDGAR2K words
2026-08-040001193125-26-332752EDGAR3K words
2026-04-020001193125-26-140027EDGAR1K words
2026-03-040001193125-26-091880EDGAR1K words
2026-03-020001193125-26-085399EDGAR3K words
2025-12-010001193125-25-303162EDGAR1K words
2025-11-050001193125-25-266916EDGAR3K words
2025-08-220001193125-25-185553EDGAR1K words
2025-08-140000950170-25-108876EDGAR3K words

72 total filings indexed. 45 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

targeted-oncology urothelial-cancers skeletal-dysplasia-/-rare-genetic-conditions hepatocellular-carcinoma intrahepatic-cholangiocarcinoma

Company Identity

CIK0001863127
TickerTYRA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.tyra.bio
Listed2021-09-15

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 28c62e54fc454e97b3d70cb863fe440ad512077955f1e0be13f2626ded56a932
parent: 3d9487c4a8831053331004b1bdfe7d4eb5ea49e1221d453df8e64b7302069f8d
content hash: 2530ecc88b6d03a6107fb2f0b827219b6466002dab2ab4e29f747eb6e7ec7408
signed: 2026-09-30T12:03:18.515Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up TYRA using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on TYRA, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/TYRA (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.